Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens

被引:47
作者
Chou, Sunwen
Marousek, Gail I.
Van Wechel, Laura C.
Li, Shaobing
Weinberg, Adriana
机构
[1] VA Med Ctr, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[3] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO USA
[4] Univ Colorado, Hlth Sci Ctr, Div Pediat Infect Dis, Denver, CO USA
关键词
D O I
10.1128/AAC.00736-07
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Recombinant phenotyping of cytomegalovirus (CMV) pol region III mutations from clinical specimens showed that T813S and G841A each conferred foscarnet resistance and approximately threefold increased ganciclovir resistance; adding the UL97 mutation C592G increased ganciclovir resistance to approximately sixfold. Bacterial artificial chromosome CMV clones containing pol mutation L845P were nonviable unless repaired with the wild-type sequence.
引用
收藏
页码:4160 / 4162
页数:3
相关论文
共 14 条
[1]
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli:: a new approach for construction of HCMV mutants [J].
Borst, EM ;
Hahn, G ;
Koszinowski, UH ;
Messerle, M .
JOURNAL OF VIROLOGY, 1999, 73 (10) :8320-8329
[2]
Cytomegalovirus UL97 kinase mutations that confer maribavir resistance [J].
Chou, Sunwen ;
Van Wechel, Laura C. ;
Marousek, Gail I. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (01) :91-94
[3]
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy [J].
Chou, SW ;
Marousek, G ;
Parenti, DM ;
Gordon, SM ;
La Voy, AG ;
Ross, JG ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :526-530
[4]
Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene [J].
Chou, SW ;
Van Wechel, LC ;
Lichy, HM ;
Marousek, GI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2710-2715
[5]
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[6]
A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture [J].
Cihlar, T ;
Fuller, MD ;
Mulato, AS ;
Cherrington, JM .
VIROLOGY, 1998, 248 (02) :382-393
[7]
Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments [J].
Cihlar, T ;
Fuller, MD ;
Cherrington, JM .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5927-5936
[8]
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients [J].
Erice, A ;
GilRoda, C ;
Perez, JL ;
Balfour, HH ;
Sannerud, KJ ;
Hanson, MN ;
Boivin, G ;
Chou, SW .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1087-1092
[9]
Human cytomegalovirus resistance to antiviral drugs [J].
Gilbert, C ;
Boivin, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :873-883
[10]
Crystal structure of the herpes simplex virus 1 DNA polymerase [J].
Liu, Shenping ;
Knafels, John D. ;
Chang, Jeanne S. ;
Waszak, Gregory A. ;
Baldwin, Eric T. ;
Deibel, Martin R., Jr. ;
Thomsen, Darrell R. ;
Homa, Fred L. ;
Wells, Peter A. ;
Tory, Monica C. ;
Poorman, Roger A. ;
Gao, Hua ;
Qiu, Xiayang ;
Seddon, Andrew P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (26) :18193-18200